CUSIP 86150R107 · who reports it, how much, and how much it matters to them
25 of the 720 hedge fund managers we track reported shares of Stoke Therapeutics, Inc. (Nasdaq: STOK) on Form 13F for 30 June 2026. Between them they reported USD 538m. The largest position belongs to RTW Investments, at USD 184m. The manager with the most riding on it is Redmile Group, where it is 8.7% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | RTW Investments2 funds on PPLI.com | USD 184m | 1.6% |
| 2 | Redmile Group10 funds on PPLI.com | USD 129m | 8.7% |
| 3 | Baker Bros. Advisors2 funds on PPLI.com | USD 109m | 0.5% |
| 4 | Polar Capital LLP26 funds on PPLI.com | USD 27m | 0.1% |
| 5 | ECOR1 Capital3 funds on PPLI.com | USD 24m | 1.2% |
| 6 | Citadel Advisors32 funds on PPLI.com | USD 16m | 0.0% |
| 7 | Artisan Partners1 fund on PPLI.com | USD 12m | 0.0% |
| 8 | Millennium Management6 funds on PPLI.com | USD 8.5m | 0.0% |
| 9 | Dafna Capital Management6 funds on PPLI.com | USD 4.3m | 0.8% |
| 10 | Exoduspoint Capital Management7 funds on PPLI.com | USD 4.2m | 0.0% |
| 11 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 3.3m | 0.0% |
| 12 | Palo Alto Investors6 funds on PPLI.com | USD 2.8m | 0.4% |
| 13 | Boothbay Fund Management2 funds on PPLI.com | USD 2.6m | 0.0% |
| 14 | Two Sigma Investments35 funds on PPLI.com | USD 2m | 0.0% |
| 15 | HighVista Strategies27 funds on PPLI.com | USD 2m | 0.5% |
| 16 | D. E. Shaw & Co.15 funds on PPLI.com | USD 1.9m | 0.0% |
| 17 | Platinum Investment Management11 funds on PPLI.com | USD 1.3m | 0.3% |
| 18 | Squarepoint Ops7 funds on PPLI.com | USD 959,000 | 0.0% |
| 19 | Balyasny Asset Management25 funds on PPLI.com | USD 652,000 | 0.0% |
| 20 | Aquatic Capital Management3 funds on PPLI.com | USD 506,000 | 0.0% |
| 21 | Jain Global1 fund on PPLI.com | USD 356,000 | 0.0% |
| 22 | Capstone Investment Advisors25 funds on PPLI.com | USD 314,000 | 0.0% |
| 23 | Prelude Capital Management9 funds on PPLI.com | USD 248,000 | 0.0% |
| 24 | Magnetar Financial93 funds on PPLI.com | USD 205,000 | 0.0% |
| 25 | The Quarry1 fund on PPLI.com | USD 15,640 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Redmile Group | USD 129m | 8.7% |
| 2 | RTW Investments | USD 184m | 1.6% |
| 3 | ECOR1 Capital | USD 24m | 1.2% |
| 4 | Dafna Capital Management | USD 4.3m | 0.8% |
| 5 | Baker Bros. Advisors | USD 109m | 0.5% |
| 6 | HighVista Strategies | USD 2m | 0.5% |
| 7 | Palo Alto Investors | USD 2.8m | 0.4% |
| 8 | Platinum Investment Management | USD 1.3m | 0.3% |
| 9 | Polar Capital LLP | USD 27m | 0.1% |
| 10 | Boothbay Fund Management | USD 2.6m | 0.0% |
Stoke Therapeutics, Inc. trades under the symbol STOK on the Nasdaq. Its CUSIP, the code used on Form 13F, is 86150R107.
25 of the 720 hedge fund managers PPLI.com tracks reported Stoke Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by RTW Investments (USD 184m), Redmile Group (USD 129m), Baker Bros. Advisors (USD 109m), Polar Capital LLP (USD 27m) and ECOR1 Capital (USD 24m).
25 managers in our coverage reported it, and between them they run 385 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Redmile Group, where the position was 8.7% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Stoke Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.